Current funding opportunities relevant to researchers in the ABA community can be found here. Be sure to check back for updates. If you know of an opportunity that should be listed here, please contact the Central Office.
Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)
The purpose of the Funding Opportunity Announcement (FOA) is to promote the assessment and further development of simulation technologies intended to improve patient safety and healthcare outcomes provided by practicing patient care providers and experienced (not trainee) physicians. The FOA seeks applications directed toward three areas of research: 1) Skill Acquisition: to evaluate strategies and protocols for simulation-based methods for skill acquisition and maintenance by experienced clinicians; 2) Outcomes Assessment: to assess the relationship of simulation-based assessments of skills demonstrated by experienced clinicians with the quality of clinical care delivered by those clinicians, and to identify strategies to increase the quality of simulation-based assessments of skills; and 3) Technology Development: to develop virtual coaches by incorporating intelligent technologies into existing simulators to provide adaptive, cognitive assistance to coach experienced practitioners in retaining, retraining and improving performance levels in the context of the user environment (and physiological system as appropriate).
Announced: November 13, 2018
Due: January 7, 2022
Amount: Not Specified
Research Project Grant (Parent R01 Clinical Trial Required)
The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH’s definition of a clinical trial through this funding opportunity announcement.
Announced: November 5, 2018
Due: February 1, 2022
Amount: Not Specified
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Announced: October 4, 2018
Due: October 1, 2021
Notice of Intent to Publish Funding Opportunity Announcements for the Collaborative Pediatric Critical Care Research Network (CPCCRN) (R01 Clinical Trial Optional
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish Funding Opportunity Announcements (FOAs) to re-issue Requests for Applications (RFAs) for both the Collaborative Pediatric Critical Care Research Network (CPCCRN) Clinical Centers and Data Coordinating Center. This re-competition will differ from prior competitions in that the CPCCRN grants will no longer be awarded using a Cooperative Agreement mechanism, because NIH will no longer have a substantive scientific role in performing the research.along with the investigators. Instead, grantees will now be expected to work independently, with NIH staff providing the level of monitoring and oversight typically found in investigator-initiated grants. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Winter 2019 with an expected application due date in Summer 2020. This Funding Opportunity Announcement (FOA) will utilize the RL1 (Clinical Trial Optional) activity code. Details of the planned FOA are provided below.
Announced: September 5, 2018
Due: December 1, 2019
Amount: Not Specified